Genetics and genomics in human lung transplantation

Area of Science:

• Immunology
• Genetics
• Transplantation Biology

Background:

• Lung transplantation is a vital treatment for end-stage lung disease, but long-term survival is limited by graft rejection.
• Acute and chronic rejection remain major obstacles, hindering broader application of lung transplantation.
• Current understanding of rejection mechanisms and effective animal models are insufficient.

Purpose of the Study:

• To review the application of genomics and genetics in lung transplantation.
• To highlight how systems biology approaches can improve understanding of transplant rejection.
• To explore the potential for genomics in clinical practice and basic transplant research.

Main Methods:

• Utilizing a systems-biology approach, including genomics and gene expression profiling.
• Analyzing T-cell activation pathways and the roles of B cells and innate immunity.
• Reviewing emerging genetic and genomic applications in human lung transplantation.

Main Results:

• Systems biology has provided new insights into the pathogenesis of lung transplant rejection.
• Genomics and gene expression profiling have elucidated mechanisms of T-cell activation.
• The involvement of B cells and innate immunity in rejection processes has been uncovered.

Conclusions:

• Genomics and genetics are revolutionizing the study of lung transplantation.
• These approaches offer potential for minimally invasive rejection diagnosis.
• Individually tailored immunosuppressive regimens may become feasible through genetic insights.